Health & Medicine
A popular sunscreen ingredient can finally be sold in the United States
The FDA will allow bemotrizinol in sunscreen. The chemical is long-lasting and defends against solar radiation that ages skin.
Health & Medicine
More Stories in Health & Medicine
- Health & Medicine
Measles has no treatments. Changing that may not be easy
Vaccination remains the priority, but some researchers are looking for drugs to fight the virus in people who don't get the shot.
- Health & Medicine
A new guideline links care for heart, kidney and metabolic diseases
A guideline treats heart disease, kidney disease, diabetes and obesity as connected conditions under one umbrella: CKM syndrome.
- Health & Medicine
Sleep and exercise may dampen genetic drivers of heart disease
Over time, immune cells acquire mutations that promote atherosclerosis. Lifestyle changes may offset these DNA glitches, new mouse data suggest.
- Health & Medicine
Engineered hookworms could one day dispense drugs from inside your gut
In a first, researchers genetically modified hookworms. It’s a step toward turning the parasites into living pharmacies.
- Health & Medicine
A drug may help people on GLP-1 meds preserve muscle
In a clinical trial, an experimental antibody reduced lean-mass loss in people on a GLP-1 drug. Whether that improves health is unclear.
- Health & Medicine
Curbing Congo’s Ebola outbreak is hampered by unknowns about the virus
Answers to key questions could help public health officials develop Ebola treatments, predict the outbreak’s trajectory and prevent a future one.
- Health & Medicine
More young people are looking to AI chatbots for mental health help
A new survey estimates 8 million young people use AI chatbots for help when stressed, angry or sad, an increase from 2024.
- Neuroscience
A tiny part of your brain may still listen under anesthesia
Tones, oddball sounds and words can spark brain cell responses, hinting at nuanced processing without consciousness.
- Health & Medicine
A new pancreatic cancer pill may be a game changer for patients
Daraxonrasib, which nearly doubled patients' survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.
